People: ACADIA Pharmaceuticals Inc (ACAD.O)

ACAD.O on Nasdaq

20.16USD
22 Jul 2014
Price Change (% chg)

$-0.15 (-0.74%)
Prev Close
$20.31
Open
$20.47
Day's High
$20.63
Day's Low
$20.00
Volume
769,108
Avg. Vol
1,304,153
52-wk High
$32.00
52-wk Low
$15.64

Search Stocks

Hacksell, Uli 

Brief Biography

Dr. Uli Hacksell Ph.D., serves as President, Chief Executive Officer, Director of ACADIA Phamaceuticals Inc. Previously, he was President, Chief Executive Officer, Director of the Company since 2009. From February 1999 to September 2000, he served as Executive Vice President of Drug Discovery. From August 1991 to February 1999, Dr. Hacksell held various senior executive positions at Astra, a pharmaceutical company, including Vice President of Drug Discovery and Technology as well as President of Astra Draco, development subsidiaries, where he directed an organization of more than 1,100 employees. From August 1991 to May 1994, he served as Vice President of CNS Preclinical R&D at Astra Arcus, another subsidiary. Earlier in his career, Dr. Hacksell held the positions of Professor of Organic Chemistry and Department Chairman at Uppsala University in Sweden and also served as Chairman and Vice Chairman of the European Federation of Medicinal Chemistry. He currently serves on the board of directors of SLS Invest AB. Dr. Hacksell received a Master of Pharmacy and a Ph.D. in Medicinal Chemistry from Uppsala University.

Basic Compensation

Total Annual Compensation, USD Long-Term Incentive Plans, USD All Other, USD Fiscal Year Total, USD
935,000 -- 3,883,870 4,818,870

Options Compensation

  Quantity Market Value
Exercisable 339,084 2,862,580.00
Unexercisable 75,000 217,500.00
Exercised 193,500 2,726,310.00
Name Fiscal Year Total

Leslie Iversen

--

Uli Hacksell

4,818,870

Stephen Davis

--

Roger Mills

2,876,290

Terrence Moore

2,452,450

Glenn Baity

2,135,770
As Of 30 Dec 2013
Search Stocks